🇺🇸 FDA

Intelligence · Patent portfolio

Paxlovid Patents

Full USPTO pharma patent portfolio for Paxlovid — grant dates, expiration, and drug cross-links.

Patents
193
Expiring ≤24m
2

Quick answer

Paxlovid has 193 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 2 expire within 24 months — use filters for patent-cliff planning.

Page 2 of 5

  1. US 10806700

    Oral dosage forms for delivery of therapeutic agents

    Expires Mon Oct 15 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 10799092

    System and method for cleansing segments of a luminal network

    Expires Mon Oct 08 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 10799485

    Methods and compositions for treatment of epileptic disorders

    Expires Mon Oct 08 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 10765646

    Methods of treating developmental encephalopathies

    Expires Mon Sep 03 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 10765666

    Use of gaboxadol for the treatment of Tourette syndrome, tics and stuttering

    Expires Mon Sep 03 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 10736894

    Methods of treating developmental syndromes with PDE10A inhibitors

    Expires Mon Aug 06 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 10653652

    Use of (1S,3S)-3-amino-4-(difluoromethylidene) cyclopentane-1-carboxylic acid and (S)-3-amino-4-(difluoromethylenyl)cyclopent-1-ene-1-carboxylic acid in the treatment of tinnitus, acute sensorineural hearing loss, meniere'S disease, tourette'S syndrome, attention deficit hyperactivity disorder and addiction

    Expires Mon May 14 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 10603308

    Methods and compositions for treatment of epileptic disorders

    Expires Mon Mar 26 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 10597731

    Allogeneic autophagosome-enriched composition for the treatment of disease

    Expires Mon Mar 19 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 10597732

    Allogeneic autophagosome-enriched composition for the treatment of disease

    Expires Mon Mar 19 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 10576099

    Injectable scaffold for treatment of intracranial aneurysms and related technology

    Expires Mon Feb 27 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 10561744

    Multi-encapsulated formulations made with oxidized cellulose

    Expires Mon Feb 13 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 10493069

    Methods of treating behavioral syndromes using pipradrol

    Expires Mon Nov 28 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 10449152

    Drug loaded microspheres for post-operative chronic pain

    Expires Mon Oct 17 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 10426746

    Methods of treating developmental disorders with biguanides

    Expires Mon Sep 26 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 10426730

    Oxidized cellulose microspheres

    Expires Mon Sep 26 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 10420773

    Methods of treating developmental disorders and/or seizure disorders with etifoxine

    Expires Mon Sep 19 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 10413566

    Thixotropic oxidized cellulose solutions and medical applications thereof

    Expires Mon Sep 12 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. US 10398778

    Method for enhancing specific immunotherapies in cancer treatment

    Expires Mon Aug 29 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. US 10363246

    Methods and compositions for treatment of epileptic disorders

    Expires Mon Jul 25 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  21. US 10328095

    Resorbable oxidized cellulose embolization microspheres

    Expires Mon Jun 20 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  22. US 10327853

    System and method of performing treatment along a lumen network

    Expires Mon Jun 20 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  23. US 10265300

    Methods of treating seizure disorders

    Expires Mon Apr 18 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  24. US 10226518

    Ubiquitinylated proteins

    Expires Mon Mar 07 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  25. US 10195165

    Methods of treating Prader-Willi syndrome

    Expires Mon Jan 31 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  26. US 10188635

    Use of gaboxadol in the treatment of tinnitus

    Expires Mon Jan 24 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  27. US 10188608

    Oxidized cellulose microspheres

    Expires Mon Jan 24 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  28. US 10123979

    Methods of treating developmental disorders with biguanides

    Expires Mon Nov 08 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  29. US 10111865

    Methods of sedation during critical care treatment

    Expires Mon Oct 25 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  30. US 10086105

    Chitosan foam medical devices and methods

    Expires Mon Sep 27 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  31. US 10071083

    Use of gaboxadol in the treatment of tinnitus

    Expires Mon Sep 06 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  32. US 9993543

    Immunogenic compositions comprising silicified virus and methods of use

    Expires Mon Jun 07 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  33. US 9920378

    Allogeneic autophagosome-enriched composition for the treatment of disease

    Expires Mon Mar 15 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  34. US 9919063

    Multi-encapsulated formulations made with oxidized cellulose

    Expires Mon Mar 15 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  35. US 9913833

    Methods of treating developmental disorders using pipradrol

    Expires Mon Mar 08 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  36. US 9889230

    Hemostatic implant

    Expires Mon Feb 08 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  37. US 9872935

    Hydrogel implants with varying degrees of crosslinking

    Expires Mon Jan 18 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  38. US 9872909

    Method for enhancing specific immunotherapies in cancer treatment

    Expires Mon Jan 18 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  39. US 9861590

    Self-supporting films for delivery of therapeutic agents

    Expires Mon Jan 04 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  40. US 9828432

    Cancer treatment and monitoring methods using OX40 agonists

    Expires Mon Nov 23 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  41. US 9827233

    Methods of treating behavioral syndromes using pipradrol

    Expires Mon Nov 23 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  42. US 9801812

    Injectable non-aqueous compositions and methods of treating vascular disease

    Expires Mon Oct 26 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  43. US 9801864

    Methods of increasing tonic inhibition and treating secondary insomnia

    Expires Mon Oct 26 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  44. US 9782430

    Resorbable oxidized cellulose embolization solution

    Expires Mon Oct 05 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  45. US 9775891

    Methods and compositions for inducing an immune response to EGFRvIII

    Expires Mon Sep 28 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  46. US 9744159

    Methods of treatment Rett syndrome

    Expires Mon Aug 24 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  47. US 9738678

    Substituted nucleoside derivatives with antiviral and antimicrobial properties

    Expires Mon Aug 17 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  48. US 9717716

    Methods of sedation during critical care treatment

    Expires Mon Jul 27 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

How many patents does Paxlovid have?

193 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).

When do Paxlovid patents expire?

2 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.

Where does this data come from?

USPTO PatentsView bulk data filtered to pharmaceutical CPC classes (A61K, A61P), cross-linked to NovaPharmaNews company and drug profiles. See our data sources page for methodology.

Data attribution: Data sources · Patent directory

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.